Walleye Capital’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$147K Sell
23,296
-9,584
-29% -$64.7K ﹤0.01% 3686
2026
Q1
$214K Sell
32,880
-5,025
-13% -$31.2K ﹤0.01% 3306
2025
Q4
$217K Sell
37,905
-25,802
-41% -$159K ﹤0.01% 3503
2025
Q3
$434K Buy
63,707
+32,605
+105% +$247K ﹤0.01% 2733
2025
Q2
$279K Buy
31,102
+17,414
+127% +$103K ﹤0.01% 3100
2025
Q1
$73.6K Sell
13,688
-3,761
-22% -$25.6K ﹤0.01% 3728
2024
Q4
$130K Sell
17,449
-8,017
-31% -$65.9K ﹤0.01% 4007
2024
Q3
$230K Sell
25,466
-29,486
-54% -$304K ﹤0.01% 3897
2024
Q2
$584K Buy
+54,952
New +$585K ﹤0.01% 3384

Other funds holding ULBI

Walleye Capital's ULBI Position: Q2 2026 in Review

Walleye Capital reduced its Ultralife (ULBI) stake by 29% in Q2 2026, selling an estimated $64.7K and leaving 23,296 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #3686.

Walleye Capital first reported a position in ULBI in Q2 2024 and has held it in 9 quarters since. The position peaked at $584K in Q2 2024. 52 funds tracked by Wall St. Rank hold ULBI as of Q2 2026.

  • Walleye Capital held 23,296 shares of Ultralife worth $147K as of Q2 2026.
  • Walleye Capital sold 9,584 Ultralife shares in Q2 2026, an estimated $64.7K.
  • Ultralife made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3686 holding.
  • Walleye Capital first reported a position in Ultralife in Q2 2024 and has held it in 9 quarters since.
  • Walleye Capital's Ultralife position peaked at $584K in Q2 2024.
  • 52 funds tracked by Wall St. Rank held Ultralife as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.